89bio 배당금
배당금 기준 확인 0/6
89bio does not have a record of paying a dividend.
주요 정보
n/a
배당 수익률
-21.7%
환매 수익률
총 주주 수익률 | -21.7% |
미래 배당 수익률 | 0% |
배당금 성장 | n/a |
다음 배당금 지급일 | n/a |
전 배당일 | n/a |
주당 배당금 | n/a |
지급 비율 | n/a |
최근 배당금 업데이트
업데이트 없음
Recent updates
89bio: Surviving A Competitive Space - For Now
Oct 29Health Check: How Prudently Does 89bio (NASDAQ:ETNB) Use Debt?
Sep 2689bio: Bullish In Light Of Further MOA Being Established By Peer
Aug 0789bio: Pegozafermin Could Be A Game-Changer For Liver Disease - Strong Buy
May 2389bio Still Has A Chance As NASH Race Heats Up
Oct 0689bio completes enrollment in phase 2 trial for NASH treatment
Aug 1889Bio rallies on Deep Track Capital disclosing 10% stake
Jul 0789bio: Undervalued Contender In Race For First NASH Drug Approval
Jul 20We're Hopeful That 89bio (NASDAQ:ETNB) Will Use Its Cash Wisely
May 0789bio: NASH Drug Developer With Differentiated Profile
Jan 29We're Hopeful That 89bio (NASDAQ:ETNB) Will Use Its Cash Wisely
Jan 2289bio expects to initiate Phase 2b NASH trial in 1H21
Jan 05결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: Insufficient data to determine if ETNB's dividends per share have been stable in the past.
배당금 증가: Insufficient data to determine if ETNB's dividend payments have been increasing.
시장 대비 배당 수익률
89bio 시장 대비 배당 수익률 |
---|
세그먼트 | 배당 수익률 |
---|---|
회사 (ETNB) | n/a |
시장 하위 25% (US) | 1.5% |
시장 상위 25% (US) | 4.5% |
업계 평균 (Biotechs) | 2.2% |
애널리스트 예측 (ETNB) (최대 3년) | 0% |
주목할만한 배당금: Unable to evaluate ETNB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
고배당: Unable to evaluate ETNB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
주주에 대한 수익 배당금
수익 보장: Insufficient data to calculate ETNB's payout ratio to determine if its dividend payments are covered by earnings.
주주에 대한 현금 배당금
현금 흐름 범위: Unable to calculate sustainability of dividends as ETNB has not reported any payouts.